Stock listing

OTC:ERGO Entia Biosciences Inc Stock

Follow Entia Biosciences Inc into a list and get an email when it puts out news.

Share price · OTC:ERGO

$0.0010 USD 0.0000 (0.0%)

Close on Oct 20, 2026

Past 3 months +400.0% · daily closes, Jul 13, 2026 – Oct 20, 2026, adjusted for splits
Day range
$0.0010 – $0.0010 USDOct 20, 2026
Volume
550 sharesOct 20, 2026
Market cap
$33,661 USDAt the close on Oct 20, 2026 · price × 33.66M shares outstanding
Entia Biosciences Inc logo

Daily closes

Last 3 months, Jul 20, 2026 – Oct 20, 2026 · OTC:ERGO · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$0.00100.00000.0%$0.0010$0.0010$0.0010550
$0.00100.00000.0%$0.0010$0.0010$0.00100
$0.00100.00000.0%$0.0010$0.0010$0.00100
$0.00100.00000.0%$0.0010$0.0010$0.00100
$0.00100.00000.0%$0.0010$0.0010$0.00100
$0.0010+0.0002+25.0%$0.0010$0.0010$0.001013,500
$0.00080.00000.0%$0.0008$0.0008$0.00080
$0.00080.00000.0%$0.0008$0.0008$0.00080
$0.00080.00000.0%$0.0008$0.0008$0.00080
$0.00080.00000.0%$0.0008$0.0008$0.00080
$0.00080.00000.0%$0.0008$0.0008$0.00080
$0.00080.00000.0%$0.0008$0.0008$0.00080
$0.00080.00000.0%$0.0008$0.0008$0.00080
$0.00080.00000.0%$0.0008$0.0008$0.00080
$0.00080.00000.0%$0.0008$0.0008$0.00080
$0.00080.00000.0%$0.0008$0.0008$0.00080
$0.00080.00000.0%$0.0008$0.0008$0.00080
$0.00080.00000.0%$0.0008$0.0008$0.00080
$0.00080.00000.0%$0.0008$0.0008$0.00080
$0.00080.00000.0%$0.0008$0.0008$0.00080
$0.00080.00000.0%$0.0008$0.0008$0.00080
$0.00080.00000.0%$0.0008$0.0008$0.00080
$0.00080.00000.0%$0.0002$0.0008$0.0002150
$0.00080.00000.0%$0.0008$0.0008$0.00080
$0.00080.00000.0%$0.0008$0.0008$0.00080
$0.00080.00000.0%$0.0008$0.0008$0.00080
$0.00080.00000.0%$0.0008$0.0008$0.00080
$0.00080.00000.0%$0.0008$0.0008$0.00080
$0.00080.00000.0%$0.0008$0.0008$0.00080
$0.00080.00000.0%$0.0008$0.0008$0.00080
$0.00080.00000.0%$0.0008$0.0008$0.00080
$0.00080.00000.0%$0.0008$0.0008$0.00080
$0.00080.00000.0%$0.0008$0.0008$0.00080
$0.00080.00000.0%$0.0008$0.0008$0.00080
$0.0008+0.0006+300.0%$0.0008$0.0008$0.00082,000
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0001$0.0002$0.000115,699
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00021,500
$0.00020.00000.0%$0.0002$0.0002$0.0002100
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
Ticker
OTC:ERGO
Asset type
Stock
Exchange
OTC
Currency
USD

Latest news

Entia Biosciences, Inc. (OTCQB: ERGO) Enters into Exclusive Worldwide Licensing Agreement for its GROH Beauty Products Line

Feb 24, 2017

Entia Biosciences, Inc. (OTCQB: ERGO) Receives Notification of the Grant of European Patent it has Exclusively Licensed for Identifying the Ergothioneine Transporter and its Therapeutic Uses

Nov 2, 2016

Entia Biosciences, Inc. (OTCQB: ERGO) to Present Results of Chronic Kidney Disease Medical Food Clinical Study at American Society of Nephrology / Kidney Week 2016 Annual Meeting

Oct 6, 2016

Preliminary clinical results for Entia Biosciences, Inc.’s new, proprietary ErgoD2® medical food show an average increase in kidney filtration rate of approximately 10% for over 75% of test subjects, after only three months

Sep 26, 2016

UPDATE -- Entia Biosciences, Inc. Begins Clinical Study of Proprietary ErgoD2® Medical Food Product to Demonstrate Improved Health for the More Than 25 Million Chronic Kidney Disease Sufferers in the U.S.

Dec 21, 2015

Ergomed Increases Its Co-Development Contribution up to $12,000,000 in CEL-SCI’s Phase 3 Head and Neck Cancer Trial

Oct 5, 2015

Issued by another party

OTC Markets Group Welcomes Newly Verified OTCQB Companies – May 18

May 18, 2015

All Entia Biosciences Inc news

Entia Biosciences Inc on 6ix

News releases
8 in all · newest Feb 24, 2017 · oldest 2015

Log in to ask 6ix AI your own questions about Entia Biosciences Inc.